Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CHOLINE FENOFIBRATE, with a corresponding US DMF Number 23268.
Remarkably, this DMF maintains an Active status since its submission on November 13, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 21, 2017, and payment made on June 21, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II